Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa M Ledet

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The Prostate|September 13, 2021
Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutationsAlexandra O Sokolova, Catherine H Marshall, Rebeca Lozano, et al.
The Prostate|April 1, 2021
Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancerElisa M Ledet, Earle F Burgess, Alexandra O Sokolova, et al.
Medrxiv : the Preprint Server for Health Sciences|December 11, 2023
Genomic and epigenomic analysis of plasma cell-free DNA identifies stemness features associated with worse survival in <i>AR</i> -altered lethal prostate cancerPradeep S Chauhan, Irfan Alahi, Savar Sinha, et al.
European Urology Oncology|July 12, 2025
Efficacy of Anti-PD-(L)1 Immunotherapy in Patients with DNA Mismatch Repair-deficient Metastatic Castration-resistant Prostate CancerSandra van Wilpe, Tarek Taha, Emily C Rothmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2024
Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate CancerPradeep S Chauhan, Irfan Alahi, Savar Sinha, et al.
European Urology|December 5, 2021
Inherited TP53 Variants and Risk of Prostate CancerKara N Maxwell, Heather H Cheng, Jacquelyn Powers, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The Prostate|September 13, 2021
Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutationsAlexandra O Sokolova, Catherine H Marshall, Rebeca Lozano, et al.
The Prostate|April 1, 2021
Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancerElisa M Ledet, Earle F Burgess, Alexandra O Sokolova, et al.
Medrxiv : the Preprint Server for Health Sciences|December 11, 2023
Genomic and epigenomic analysis of plasma cell-free DNA identifies stemness features associated with worse survival in <i>AR</i> -altered lethal prostate cancerPradeep S Chauhan, Irfan Alahi, Savar Sinha, et al.
European Urology Oncology|July 12, 2025
Efficacy of Anti-PD-(L)1 Immunotherapy in Patients with DNA Mismatch Repair-deficient Metastatic Castration-resistant Prostate CancerSandra van Wilpe, Tarek Taha, Emily C Rothmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2024
Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate CancerPradeep S Chauhan, Irfan Alahi, Savar Sinha, et al.
European Urology|December 5, 2021
Inherited TP53 Variants and Risk of Prostate CancerKara N Maxwell, Heather H Cheng, Jacquelyn Powers, et al.
Pageof 3